Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | WRN | Q14191 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7813401 | 0.92 | NAAA (0.46) | TDP1NAAAALDH1A1CYP1A2HPGD | |
| SCHEMBL12189506 | 0.84 | NAAA (0.41) | TDP1NAAAALDH1A1CYP1A2HPGD | |
| SCHEMBL14535001 | 0.82 | TDP1 (0.41) | TDP1NAAAALDH1A1CYP1A2HPGD | |
| SCHEMBL28131182 | 0.82 | NAAA (0.40) | TDP1NAAAALDH1A1CYP1A2HPGD | |
| SCHEMBL11312957 | 0.82 | PAM (0.55) | TDP1ALDH1A1CYP1A2PAMLMNA | |
| SCHEMBL28788408 | 0.82 | TDP1 (0.41) | TDP1NAAAALDH1A1GAAMGAM | |
| SCHEMBL11587311 | 0.82 | ALDH1A1 (0.50) | TDP1NAAAALDH1A1CYP1A2HPGD | |
| SCHEMBL16907299 | 0.82 | ALDH1A1 (0.56) | TDP1NAAAALDH1A1CYP1A2PAM | |
| SCHEMBL13593710 | 0.80 | TDP1 (0.39) | TDP1NAAAALDH1A1CYP1A2GAA | |
| SCHEMBL11469977 | 0.80 | GAA (0.42) | TDP1NAAAALDH1A1CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4342920-A1 | SILICONE CHAIN-CONTAINING POLYMER, COATING COMPOSITION, RESIST COMPOSITION AND ARTICLE | DIC CORPORATION (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-104662004-B | Novel rebamipide prodrug, method for producing same, and usage thereof | 三进制药株式会社 | 2017-04-19 | — | — | CN | disclosed |
| US-20160215022-A1 | CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF | APELLIS PHARMACEUTICALS, INC. | 2016-07-28 | — | — | US | disclosed |
| US-20160215020-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | APELLIS PHARMACEUTICALS, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| US-20160194359-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | APELLIS PHARMACEUTICALS, INC. | 2016-07-07 | — | — | US | disclosed |
| EP-1698644-B1 | FLUORINE-CONTAINING PHOTOCURING COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-7601781-B2 | Curable compositions | KANEKA CORPORATION (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7592405-B2 | Fluorine-containing photocurable composition | DIC CORPORATION (JP) | 2009-09-22 | — | — | US | disclosed |
| US-20080177001-A1 | CURABLE COMPOSITIONS | KANEKA CORPORATION (JP) | 2008-07-24 | — | — | US | disclosed |
| US-7304110-B2 | Polymer, process for producing the polymer and curable composition containing the polymer | KANEKA CORPORATION (JP) | 2007-12-04 | — | — | US | disclosed |
| US-20070066779-A1 | Fluorine-containing photocurable composition | DIC CORPORATION (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1698644-A1 | FLUORINE-CONTAINING PHOTOCURING COMPOSITION | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-09-06 | — | — | EP | disclosed |
| EP-1278747-A1 | PYRANO, PIPERIDINO, AND THIOPYRANO COMPOUNDS AND METHODS OF USE | Abbott Laboratories (US) | 2003-01-29 | — | — | EP | disclosed |
| WO-2001083484-A1 | PYRANO, PIPERIDINO, AND THIOPYRANO COMPOUNDS AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2001-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160215022-A1 | CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF | C9, C3AR1, SERPINC1 | TDP1 2394/4885NAAA 1237/4885ALDH1A1 4856/4885 |
| US-20160215020-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | C3AR1, C9, C1QBP | TDP1 1714/4885NAAA 1882/4885ALDH1A1 4770/4885 |
| US-20160194359-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | C3AR1, C9, C1QBP | TDP1 1719/4885NAAA 1884/4885ALDH1A1 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.